Inside Kyverna

Building a company singularly focused on freeing patients from the siege of autoimmune disease.

Our story

Kyverna is pioneering CAR T-cell therapies for autoimmune disease patients by harnessing the power of T cells to achieve a potentially treatment-free remission by resetting the immune system.

Applying cell therapy to autoimmune diseases

Based in the San Francisco East Bay, we believe that advances in cell engineering for cancer could be applied to autoimmune diseases, where a vast number of conditions are not adequately treated by currently available therapies.

Meet our team

As leaders, we are committed to fostering a collegial, collaborative and open environment where we welcome and nurture “science of all minds” to help fulfill the promise of developing transformative cell therapies for patients with autoimmune diseases.